SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '7L6'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZBR_A_DIFA601_1 (SERUM ALBUMIN) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 5 / 9 | LEU A1086ASP A1074ALA A1077VAL A1079GLU A1070 | 7L6 A1506 (-4.2A)None7L6 A1506 (-3.6A)NoneNone | 1.45A | 4zbrA-5tuyA:undetectable | 4zbrA-5tuyA:18.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JHN_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 5 / 12 | GLY A1051TYR A1085HIS A1113TYR A1154PHE A1158 | NoneSAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A) | 1.09A | 5jhnA-5tuyA:26.4 | 5jhnA-5tuyA:97.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JHN_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158LYS A1162PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)7L6 A1506 ( 4.6A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.41A | 5jhnA-5tuyA:26.4 | 5jhnA-5tuyA:97.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JHN_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 5 / 12 | GLY A1051TYR A1085HIS A1113TYR A1154PHE A1158 | NoneSAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A) | 1.03A | 5jhnB-5tuyA:41.3 | 5jhnB-5tuyA:97.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JHN_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.38A | 5jhnB-5tuyA:41.3 | 5jhnB-5tuyA:97.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JIN_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085HIS A1113TYR A1154PHE A1158LYS A1162PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)7L6 A1506 ( 4.6A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.44A | 5jinA-5tuyA:26.3 | 5jinA-5tuyA:97.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JIN_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158LYS A1162PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)7L6 A1506 ( 4.6A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.46A | 5jinB-5tuyA:41.2 | 5jinB-5tuyA:97.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JIY_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158LYS A1162PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)7L6 A1506 ( 4.6A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.42A | 5jiyA-5tuyA:41.8 | 5jiyA-5tuyA:97.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JIY_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158LYS A1162PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)7L6 A1506 ( 4.6A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.44A | 5jiyB-5tuyA:41.1 | 5jiyB-5tuyA:97.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JJ0_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085HIS A1113TYR A1154PHE A1158LYS A1162PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)7L6 A1506 ( 4.6A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.44A | 5jj0A-5tuyA:26.5 | 5jj0A-5tuyA:97.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JJ0_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084ASN A1112HIS A1113TYR A1154PHE A1158LYS A1162PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)7L6 A1506 ( 4.6A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.44A | 5jj0B-5tuyA:41.1 | 5jj0B-5tuyA:97.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KKL_B_SAMB8009_0 (PUTATIVEUNCHARACTERIZEDPROTEIN,HISTONE H3.1PEPTIDE,ZINC FINGERDOMAIN-CONTAININGPROTEIN) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 5 / 12 | GLY A1049ASN A1112HIS A1113TYR A1154PHE A1158 | SAM A1505 ( 3.9A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A) | 0.61A | 5kklB-5tuyA:4.1 | 5kklB-5tuyA:14.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5T0K_A_SAMA1304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 5 / 12 | GLY A1051TYR A1085HIS A1113TYR A1154PHE A1158 | NoneSAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A) | 1.06A | 5t0kA-5tuyA:41.4 | 5t0kA-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5T0K_A_SAMA1304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.36A | 5t0kA-5tuyA:41.4 | 5t0kA-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5T0K_B_SAMB1304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084ASN A1112HIS A1113TYR A1154PHE A1158LYS A1162PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)7L6 A1506 ( 4.6A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.44A | 5t0kB-5tuyA:38.5 | 5t0kB-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5T0M_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158LYS A1162PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)7L6 A1506 ( 4.6A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.43A | 5t0mA-5tuyA:41.1 | 5t0mA-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5T0M_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 5 / 12 | GLY A1051TYR A1085HIS A1113TYR A1154PHE A1158 | NoneSAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A) | 1.10A | 5t0mB-5tuyA:41.5 | 5t0mB-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5T0M_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.34A | 5t0mB-5tuyA:41.5 | 5t0mB-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTF_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 11 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.21A | 5ttfA-5tuyA:42.0 | 5ttfA-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTF_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.22A | 5ttfB-5tuyA:42.1 | 5ttfB-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTF_C_SAMC1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 10 / 12 | MET A1048GLY A1049TRP A1050ASN A1112HIS A1113TYR A1154PHE A1158TRP A1159CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)None ZN A1504 (-2.2A)None | 0.71A | 5ttfC-5tuyA:41.7 | 5ttfC-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTF_C_SAMC1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 12 | MET A1048GLY A1049TRP A1050SER A1084ASN A1112HIS A1113TYR A1154PHE A1158TRP A1159PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)NoneSAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.43A | 5ttfC-5tuyA:41.7 | 5ttfC-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTF_D_SAMD1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 11 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.36A | 5ttfD-5tuyA:41.2 | 5ttfD-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTG_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 6 / 12 | GLY A1051TYR A1085HIS A1113TYR A1154PHE A1158CYH A1168 | NoneSAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A) ZN A1504 (-2.2A) | 1.34A | 5ttgA-5tuyA:39.7 | 5ttgA-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTG_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.33A | 5ttgA-5tuyA:39.7 | 5ttgA-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTG_B_SAMB1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 6 / 11 | GLY A1051TYR A1085HIS A1113TYR A1154PHE A1158CYH A1168 | NoneSAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A) ZN A1504 (-2.2A) | 1.33A | 5ttgB-5tuyA:24.5 | 5ttgB-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TTG_B_SAMB1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 11 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.36A | 5ttgB-5tuyA:24.5 | 5ttgB-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TUY_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.00A | 5tuyA-5tuyA:45.9 | 5tuyA-5tuyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TUY_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.16A | 5tuyB-5tuyA:42.4 | 5tuyB-5tuyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TUZ_A_SAMA3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 12 | MET A1048GLY A1049TRP A1050SER A1084ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168CYH A1170 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) ZN A1504 (-2.2A) | 0.37A | 5tuzA-5tuyA:25.2 | 5tuzA-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TUZ_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.31A | 5tuzB-5tuyA:24.8 | 5tuzB-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9I_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.25A | 5v9iA-5tuyA:41.3 | 5v9iA-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9I_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 11 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.26A | 5v9iB-5tuyA:41.5 | 5v9iB-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9I_C_SAMC1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 11 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.35A | 5v9iC-5tuyA:41.0 | 5v9iC-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9I_D_SAMD1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085HIS A1113TYR A1154PHE A1158TRP A1159PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)NoneSAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.43A | 5v9iD-5tuyA:41.0 | 5v9iD-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9J_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 6 / 12 | GLY A1051TYR A1085HIS A1113TYR A1154PHE A1158CYH A1168 | NoneSAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A) ZN A1504 (-2.2A) | 1.38A | 5v9jA-5tuyA:39.9 | 5v9jA-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9J_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.31A | 5v9jA-5tuyA:39.9 | 5v9jA-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9J_B_SAMB1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 6 / 12 | GLY A1051TYR A1085HIS A1113TYR A1154PHE A1158CYH A1168 | NoneSAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A) ZN A1504 (-2.2A) | 1.34A | 5v9jB-5tuyA:40.2 | 5v9jB-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V9J_B_SAMB1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.33A | 5v9jB-5tuyA:40.2 | 5v9jB-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSC_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.21A | 5vscA-5tuyA:41.6 | 5vscA-5tuyA:97.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSC_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.23A | 5vscB-5tuyA:26.1 | 5vscB-5tuyA:97.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSD_A_SAMA3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 12 | MET A1048GLY A1049TRP A1050SER A1084ASN A1112HIS A1113TYR A1154PHE A1158TRP A1159PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)NoneSAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.34A | 5vsdA-5tuyA:24.9 | 5vsdA-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSD_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 6 / 12 | GLY A1051TYR A1085HIS A1113TYR A1154PHE A1158CYH A1168 | NoneSAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A) ZN A1504 (-2.2A) | 1.36A | 5vsdB-5tuyA:24.9 | 5vsdB-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSD_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.34A | 5vsdB-5tuyA:24.9 | 5vsdB-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSE_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.24A | 5vseA-5tuyA:41.9 | 5vseA-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSE_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 12 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168GLN A1169 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A)None | 0.22A | 5vseB-5tuyA:41.6 | 5vseB-5tuyA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSF_A_SAMA3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 12 | MET A1048GLY A1049TRP A1050SER A1084ASN A1112HIS A1113TYR A1154PHE A1158TRP A1159PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)NoneSAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.35A | 5vsfA-5tuyA:25.2 | 5vsfA-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VSF_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homosapiens) | 11 / 12 | MET A1048GLY A1049TRP A1050SER A1084TYR A1085ASN A1112HIS A1113TYR A1154PHE A1158PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)SAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.28A | 5vsfB-5tuyA:40.0 | 5vsfB-5tuyA:79.07 |